Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
CPRX similar filings
- 28 Jul 23 Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
- 21 Jul 23 Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
- 23 Jun 23 Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
- 1 Jun 23 Catalyst Pharmaceuticals Reports Positive Momentum in Reaffirms Full Year 2023 Total Revenue Guidance of Between
- 30 May 23 Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
- 10 May 23 Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving
- 9 May 23 Other Events
Filing view
External links